Skip to search formSkip to main contentSkip to account menu

Mirapex

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The open 6-month study (the MIRAG study) on the effect of D2/D3 dopamine agonist pramipexole (mirapex) on tremor, affective… 
2010
2010
Abstract Disorders of initiation and maintenance of sleep (DIMS), excessive daytime sleepiness (EDS) are common and clinically… 
2010
2010
Disorders of initiation and maintenance of sleep (DIMS), excessive daytime sleepiness (EDS) are common and clinically significant… 
2010
2010
The open 6-month study (the MIRAG study) on the effect of D2/D3 dopamine agonist pramipexole (mirapex) on tremor, affective… 
2009
2009
: The open 3-month study of influence of D2/D3 dopamine agonist pramipexole on of Parkinson's disease (PD) features, which are… 
2009
2009
The open 3-month study of influence of D2/D3 dopamine agonist pramipexole on of Parkinson's disease (PD) features, which are… 
2009
2009
Forty-five patients with Parkinson's disease (PD) without dementia were studied. Duration of disease was 6,02+/-3,47 years. The… 
2006
2006
The results of mirapex (pramipexol) treatment of 402 patients with Parkinson's disease and juvenile parkinsonism during the… 
2006
2006
Presented are our own results, along with literature data on dopamine receptors agonists, of Parkinson's disease (PD) therapy… 
2006
2006
Abstract Presented are our own results, along with literature data on dopamine receptors agonists, of Parkinson's disease (PD…